Product Images Oxcarbazepine

This is a description of a medication by Major pharmaceutical company. The medication is Oxcarbazepine, and it is in the form of tablets. The product comes in a pack of 100 unit dose tablets. The NDC for the product is 0904-7264-61, and there is also an alternative NDC, which is not mentioned here. A dosage instruction of 800mg is visible in the text. The medication is only available on prescription and should only be dispensed with a medication guide as directed by the prescribing physician or pharmacist.*

This appears to be a description of two versions of oxcarbazepine tablets, one with NDC 0304.7263-61 and the other with NDC 0804-7263-61. Both are unit dose tablets and appear to come with a medication guide. The second version has dosing information and storage instructions on the packaging. It is advisable to dispense this medication with caution and keep it out of reach of children.*

This is a description of a medication called Oxcarbazepine. It comes in tablet form, with 100 tablets per unit dose. There are two variations of the medication, with different NDC numbers. The pharmacist should dispense the medication with a medication guide. The dosage should be followed as suggested on the packaging with proper precautions. The medication should be kept at room temperature and away from the reach of children.*

This appears to be a graph or chart that includes a variable called "Exitrate" and a p-value of 0.0001. The chart also includes a numeric sequence of 3, 4, 5, 6, and 1, likely representing time on a trial starting from day 2 in days. The label "Placebo" is also present. It is unclear what is being studied, but it may be related to a trial comparing the placebo with an experimental treatment.*

This is a statistical analysis of a trial comparing the seizure rate between two groups over time. The log-rank test was used to compare the groups and the p-value was found to be 0.045, indicating a statistically significant difference between the groups. The table shows the number of days from the first dose to the test seizure for each group. The treatment group received oxcarbazepine while the control group received a placebo.*

This is a survival analysis output for a treatment group labeled "HIGH" with time to exit measured in days. The log-rank test resulted in a p-value of 0.0001, indicating a significant difference in survival distribution compared to other groups. The graph shows the exit rate over time for the treatment group. The label "Low" may indicate another group's exit rate or the minimum value of the "HIGH" group.*

This is a statistical output showing a Tog-rank test with a p-value of 0.0001. The graph below shows the time to exit in days for a high and low treatment group. "T" represents time and "M" represents the value of the independent variable, R.*